SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Por um escritor misterioso

Descrição

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

PDF) Changing prevalence and treatment of depression among older

NMDA receptor-targeted enrichment of CaMKIIα improves fear memory

PDF) Pharmacological treatment of generalized anxiety disorder

NMDAR-dependent long-term depression is associated with increased

NMDA receptor trafficking in synaptic plasticity and

Depolarizing GABAA current in the prefrontal cortex is linked with

Iridoids from Gardeniae fructus ameliorates depression by

Teste 2nd by Second Digital - Issuu

NMDA receptor trafficking in synaptic plasticity and

PDF) Cannabinoids and Vanilloids in Schizophrenia

Selective Effects of the Loss of NMDA or mGluR5 Receptors in the

PDF) Neuroprogression in schizophrenia: Pathways underpinning

NMDARs in Cell Survival and Death: Implications in Stroke

SciELO - Brazil - Does mismatch negativity have utility for NMDA

Frontiers Targeting mGlu Receptors for Optimization of

de por adulto (o preço varia de acordo com o tamanho do grupo)

Sugerir pesquisas